openPR Logo
Press release

Global Cardiovascular Peptides Market Key Trends & Industry Forecast 2016 - 2024

07-14-2017 04:31 PM CET | Health & Medicine

Press release from: TMR - Healthcare

Global Cardiovascular Peptides Market Key Trends & Industry

Global Cardiovascular Peptides Market: Overview

Peptide therapeutics has been around for decades, but recently there has been an incease in interest of the pharmaceutical companies. Targeted therapies have proven to be cost-effective with less toxicity than their biological equivalents. Cardiovascular peptides are used in the treatment of myocardial infarction, heart failure, hypertension, thrombosis, hemostasis, wound care and peripheral vascular diseases. Targeting peptides has also been identified as a technique for the diagnosis of cardiovascular diseases. For example, blood measurement of B-type natriuretic peptide (BNP) and N-terminal-proBNP (NT-proBNP) is used in the diagnosis of congestive heart failure (CHF).

Peptides developed for the treatment and prognosis of cardiovascular diseases include lactokinins, casokinins, gliadin hydrolysate, wheat gluten hydrolysate, casoplatelin, casopiastrin and peptides derived from β-LG. These peptides have different therapeutic indications depending on their biological activity. For instance, lactokinins, casokinins and gliadin hydrolysate are used in the treatment of hypertension whereas; casoplatelin and casopiastrin are indicated for the treatment of thrombosis. The global cardiovascular peptides market can be analyzed from the therapeutic indication point of view and from the geographical aspect. Based on the geography, the global cardiovascular peptides market is categorized in four major segments - North America, Europe, Asia Pacific and Rest of the World.

Obtain Report Details @
http://www.transparencymarketresearch.com/cardiovascular-peptides-market.html

Global Cardiovascular Peptides Market: Trends and Opportunity

Research and development in this arena has surged significantly realizing the therapeutic efficacy of peptide-based active pharmaceutical ingredients. Companies are collaborating to expedite the development of new peptide-based pharmaceutical product. Nile Therapeutics Inc. and Capstone Therapeutics are working in collaboration with American Peptide Company to develop peptide-based therapies for cardiovascular diseases, specifically for heart failure. Nile’s CD-NP is a novel natriuretic peptide in the clinical development stage intended for the treatment of acute decompensated heart failure (ADHF). This peptide is intended to reduce pressure between the heart and the lungs and improve kidney function while attenuating hypotension by having least effect on the systemic blood pressure. Positive results from the trials would lead to the development of a natriuretic peptide for cardiovascular disease with better efficacy than the current therapies.

According to the World Health Organization (WHO) cardiovascular is the leading cause of death globally of which about 80% occur in the low- and middle-income countries. Moreover, it is projected to be the leading cause of death till 2030. Development of a targeted novel peptide for the treatment of cardiovascular disorders, would improve the treatment regimen to a great extent. Life expectancy of patients would increase significantly. Moreover, peptide therapeutics holds vast opportunities in the Asia Pacific and Latin American regions where cardiovascular disorders are a major cause of deaths. According to the Heart Foundation, cardiovascular is the leading cause of death in Australia which caused 43,946 deaths in 2012. Targeted cardiovascular peptide therapies would decrease the risk of heart failure by reducing the associated risks of peripheral arterial diseases, myocardial infarction and hypertension.

Significant benefits of peptides such as fewer immunogenicity issues than biologics and flexibility in terms of manufacturing all types of formulations have been the major reasons for increased interest of pharmaceutical companies in developing cardiovascular peptide therapeutics. However, short serum half-life, and sensitivity to serum and tissue proteases have been the major restraints for the commercialization of products in the market. This however, is would be addressed with development of new technologies creating a great potential for the future of cardiovascular treatment therapies.

Global Cardiovascular Peptides Market: Key Players

Some of the key players involved in the global cardiovascular peptides market include F. Hoffmann La Roche, Merck, Nile Therapeutics Inc., Biocon, Nobex Corporation, Capstone Therapeutics and American Peptide Company.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6263

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Cardiovascular Peptides Market Key Trends & Industry Forecast 2016 - 2024 here

News-ID: 625703 • Views:

More Releases from TMR - Healthcare

Clinical Trial Management System (CTMS) Market : Projection of Each Major Segment over the Forecast Period
Clinical Trial Management System (CTMS) Market : Projection of Each Major Segmen …
With companies long having realized that the best way to remain competitive in the pharmaceutical industry is by ploughing back of profits into R&D projects, the demand for clinical trial management systems is expected to see an uptick. While this will help impel the market greatly in the coming years, what also needs to be taken into consideration that the cost of implementing such a system may deter investment decisions. The
Electronic Health Records Market : Industry Analysis and Detailed Profiles of to …
The global market for electronic health record (EHR) features a largely fragmented vendor landscape, with the presence of a large number of small and large players and the top five companies cumulatively accounting for a nearly 44% of the overall market in 2016. Leading vendors in the global EHR market are adopting inorganic growth strategies such as mergers and acquisitions to expand their reach across high-growth potential regional markets, consolidate
Fuel Oil Market Intelligence Report Offers Growth Prospects
Fuel Oil Market Intelligence Report Offers Growth Prospects
The global transportation industry has been growing at a significant pace since the past decade. Companies operating in the transportation industry are the largest consumers of the fuel oil. Apart from this, fuel oil also finds application in the petrochemical industry and petroleum refineries. The building materials industry is also on the rise since many years. The demand for fuel oil is expected to increase from the building materials industry.
Thermoset Resin Market Global Industry Analysis, Trends and Forecast, 2016 - 2024
Thermoset Resin Market Global Industry Analysis, Trends and Forecast, 2016 - 202 …
The global composite industry has been expanding significantly in terms of production, technological advancements, and developments. Thermoset resin plays a vital role in the composite industry. Thermoset resins are used extensively in the manufacture of composites; these resins are employed in the fabrication of products for end-use industries such as aerospace, automotive, sporting goods, construction, electronics, and wind energy. The thermoset resin market can be segmented into six resin types:

All 5 Releases


More Releases for Peptide

Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established
What's driving the Customized Peptide Synthesis Market Growth? | Key Players are …
The customized peptide synthesis market is projected to generate a revenue of $390.0 million by 2024 as per a recent P&S Intelligence study. The market is being progressively driven by technological innovations, growing burden of cancer and infectious diseases, increasing investments and funding for protein-based research, and rising research activities in synthetic biology. Download free report sample at: https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market/report-sample There are two main types of products available in the customized peptide synthesis
Customized Peptide Synthesis Market 2019-2024 by Top Key Players are GenScript, …
Customized peptide synthesis market is forecasted to generate revenue of $390.0 million by 2024. The market is mainly driven by increasing investments and funding for protein-based research, technological innovations, growing burden of cancer and infectious diseases, and increasing research activities in the field of synthetic biology. Download free report sample at: https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market/report-sample The different types of products available in the customized peptide synthesis market are reagents and equipment. Reagents category is expected
Peptide Synthesis Market Increasing Demand & Latest Trend with Genscript, AnaSpe …
HTF MI recently introduced United States Peptide Synthesis Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Bachem, PolyPeptide, GL Biochem, Xinbang, Hybio, USVPeptides, Thermofischer, ScinoPharm, Genscript,
Global Peptide Therapeutics Market: Cancer Treatment to Surface as Key Applicati …
Market Research Reports Search Engine (MRRSE) has been acting as an impressive data source when it comes to evaluating various industrial verticals. The research report titled “Global Peptide Therapeutics Market” offers a clear insight about the Peptide Therapeutics assessed over the global platform. This analysis proves beneficial for readers & new investors who are aiming to enter the market for Peptide Therapeutics in the near future. Click to Request a Sample:
Peptide Based Cancer Therapeutics Marke For peptide based cancer therapeutics ov …
About Peptide Based Cancer Therapeutics Market Popularity of peptide based cancer therapeutics is on the rise, owing to the positive outlook on their efficiency in treating cancer. According to the latest report published by Fact.MR, the global market for peptide based cancer therapeutics is set to reflect an above average CAGR during 2017 to 2022, to reach a valuation in excess of US$ 11,100 Mn. Incessant development in drug